Corcept Therapeutics Stock Forward View - Accumulation Distribution
| CORT Stock | USD 32.18 0.03 0.09% |
Momentum
Sell Stretched
Oversold | Overbought |
Quarterly Earnings Growth -0.22 | EPS Estimate Next Quarter -0.05 | EPS Estimate Current Year 0.384 | EPS Estimate Next Year 1.608 | Wall Street Target Price 65.4 |
The hype-based summary links Corcept Therapeutics Incorporated attention patterns with price response and peers. This view uses options positioning and short interest to outline sentiment around Corcept Therapeutics.
Short Interest Map for Corcept Therapeutics
Corcept Therapeutics short interest relative to sector peers provides additional context. If Corcept Therapeutics' short interest is significantly higher than competitors. the market may perceive company-specific risks that warrant investigation.
200 Day MA 65.8916 | Short Percent 0.1578 | Short Ratio 5.99 | Shares Short Prior Month 10 M | 50 Day MA 37.7108 |
RSI Indicator for Corcept
Corcept Therapeutics Sentiment-to-Price Pattern
The relationship between Corcept Therapeutics' news sentiment and price action reveals how efficiently the market processes new information about Corcept. Persistent sentiment-price gaps create exploitable opportunities for disciplined investors.
Investors who systematically buy Corcept Therapeutics when sentiment is deeply negative and sell when it is excessively positive have historically captured mean-reversion returns not available to purely fundamental or technical investors.
Corcept Therapeutics Implied Volatility | 2.57 |
Implied volatility in Corcept Therapeutics' options does not predict direction - it measures magnitude. An investor expecting a large move in Corcept Therapeutics stock in either direction may benefit from strategies that profit from volatility expansion.
Corcept Therapeutics after-hype prediction price | $ 32.61 |
Hype indicators are listed alongside forecasting models, technical studies, analyst consensus, and earnings expectations.
Historical Fundamental Analysis of Corcept Therapeutics can be used to cross-verify projections for Corcept Therapeutics. The view provides historical context for the projection set.Rule 16 Reference for the current Corcept contract
Using the Rule 16 heuristic, the current implied volatility suggests an average daily move of about 16.06% for the 2026-03-20 options. This estimate is a volatility reference; at $ 32.18, it implies a move of about $ 5.17 per day.
Open Interest Snapshot: Corcept 2026-03-20 Options
Outstanding Corcept Therapeutics options are captured via open interest, which provides contract-flow context.
Corcept Therapeutics Additional Predictive Modules
Most predictive techniques to examine Corcept price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Corcept using various technical indicators. When you analyze Corcept charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 0.0396 | 0.0396 |
| Check Corcept Therapeutics Volatility | Backtest Corcept Therapeutics | Information Ratio |
Corcept Therapeutics Trading Date Momentum
| On March 16 2026 Corcept Therapeutics Incorporated was traded for 32.18 at the closing time. The top price for the day was 33.12 and the lowest listed price was 31.81 . There was no trading activity during the period 0.0. Lack of trading volume on March 16, 2026 did not affect price variability. The overall trading delta against the current closing price is -0.09% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Corcept Therapeutics to competition |
Other Forecasting Options for Corcept Therapeutics
Understanding Corcept Therapeutics' price movement is a prerequisite for any investor considering Corcept as a position. Corcept Stock price charts are frequently cluttered with noise that can interfere with accurate interpretation.Corcept Therapeutics Related Equities
The following equities are related to Corcept Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Corcept Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Corcept Therapeutics Market Strength Events
For traders and investors in Corcept Therapeutics Incorporated, market strength indicators offer a quantitative framework for evaluating the stock's responsiveness to market conditions. These tools help identify when trading Corcept Therapeutics shares is most likely to generate favorable returns.
Corcept Therapeutics Risk Indicators
Analyzing Corcept Therapeutics' risk indicators provides a critical input for price forecasting and investment risk management. By quantifying the risk in Corcept Therapeutics' investment, investors can make more informed decisions about their exposure and hedging strategies.
| Mean Deviation | 3.82 | |||
| Standard Deviation | 7.56 | |||
| Variance | 57.15 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Corcept Therapeutics
The amount of media and story coverage tied to Corcept Therapeutics Incorporated can signal where market attention is concentrating at the moment. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Contributor Headline
Latest Perspective From Macroaxis
Corcept Therapeutics Short Properties
Reviewing short-oriented indicators for Corcept Therapeutics Incorporated is useful because long and short participants often create very different signals for timing and volatility. The stronger read compares short sentiment with trend behavior, volume, and the broader market narrative.
| Common Stock Shares Outstanding | 120 M | |
| Cash And Short Term Investments | 372.2 M |
Additional Tools for Corcept Stock Analysis
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |